AtriCure welcomes new CEO | Personnel Moves
November 5, 2012 by MassDevice staff
Medical device company AtriCure names a new president & CEO after posting its 3Q earnings, which came in below analysts' estimates.
AtriCure names Michael Carrel its new CEO
West Chester, Ohio-based device maker AtriCure (NSDQ:ATRC) named Michael Carrel as president, CEO and a member of the board of directors of the company, effective November 1.
Carrel will receive an annual base salary of $500,000, plus a $40,000 bonus and a year-end bonus of $62,500. He is also eligible for an annual performance bonus of up to 125% of his base salary, according to regulatory filings.
Sign up to get our free newsletters delivered straight to your inbox
Carrel was previously president & CEO at Vital Images, which was acquired by Toshiba in 2011. Carrel held the role until 2012.
"Mike brings a solid track record of establishing strategic vision, expanding businesses internationally and driving revenue growth and subsequent profitability. We look forward to his leadership and contribution here at AtriCure," director Michael Hooven said during an earnings call with investors.
AtriCure also promoted Andrew Wade to principal accounting and financial officer.
Read more
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
Navigation
NEWS
Can the FDA keep its user fee promises amid sequester?
The millions of dollars in fees that medical device companies pay for FDA review aren't exempt from...
Weight loss: EnteroMedics plans on Q1 PMA submission for Maestro device
EnteroMedics expects to file for pre-market approval from the FDA this quarter for its Maestro vagal...
Natus Medical's Q1 profits soar 1000%
Natus Medical beats Wall Street's earnings forecast with a 1,000-fold profit surge on record sales,...
Supreme Court to hear Medtronic's appeal of Boston Scientific's CRM patent win
The U.S. Supreme Court agrees to hear Medtronic's appeal of a patent infringement loss to rival...
Bayonne Medical Center tops 10 most expensive hospitals in America | MassDevice.com On-Call
The New York Times lists the 10 most expensive hospitals in the United States, based on CMS data
